Pathophysiology of Pulmonary Hypertension in Chronic Parenchymal Lung Disease

American Journal of Medicine

Volumn 129, Issue 4, 2016, Pages 366-371

  Singh, Inderjit ^a   Ma, Kevin Cong ^a   Berlin, David Adam ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Chronic obstructive pulmonary disease; Idiopathic pulmonary fibrosis; Pulmonary fibrosis; Pulmonary hypertension; Sarcoidosis

Indexed keywords

CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC PARENCHYMAL LUNG DISEASE; DISEASE ASSOCIATION; FIBROSING ALVEOLITIS; HUMAN; LUNG SARCOIDOSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; COMPLICATION; HYPERTENSION, PULMONARY; LUNG CIRCULATION; SARCOIDOSIS;

HUMANS; HYPERTENSION, PULMONARY; IDIOPATHIC PULMONARY FIBROSIS; PULMONARY CIRCULATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SARCOIDOSIS;

EID: 84961909159     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2015.11.026     Document Type: Review

References (66)

1. W. Seeger, Y. Adir, J.A. Barberà, and et al. Pulmonary hypertension in chronic lung diseases J Am Coll Cardiol 62 25 Suppl 2013 D109 D116
2. C.J. Lettieri, S.D. Nathan, S.D. Barnett, S. Ahmad, and A.F. Shorr Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis Chest 129 2006 746 752
3. A.F. Shorr, D.L. Helman, D.B. Davies, and S.D. Nathan Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics Eur Respir J 25 2005 783 788
4. S.M. Arcasoy, J.D. Christie, A. Pochettino, and et al. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation Chest 120 2001 873 880
5. A.F. Shorr, D.B. Davies, and S.D. Nathan Predicting mortality in patients with sarcoidosis awaiting lung transplantation Chest 124 2003 922 928
6. K.H. Andersen, M. Iversen, J. Kjaergaard, and et al. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease J Heart Lung Transplant 31 2012 373 380
7. M.J. Cuttica, R. Kalhan, O.A. Shlobin, and et al. Categorization and impact of pulmonary hypertension in patients with advanced COPD Respir Med 104 2010 1877 1882
8. V. Fayngersh, F. Drakopanagiotakis, F. Dennis McCool, and J.R. Klinger Pulmonary hypertension in a stable community-based COPD population Lung 189 2011 377 382
9. C.U. Andersen, S. Mellemkjaer, J.E. Nielsen-Kudsk, and et al. Echocardiographic screening for pulmonary hypertension in stable COPD out-patients and NT-proBNP as a rule-out test COPD 9 2012 505 512
10. O.A. Minai, H. Fessler, J.K. Stoller, and et al. Clinical characteristics and prediction of pulmonary hypertension in severe emphysema Respir Med 108 2014 482 490
11. S.D. Nathan, O.A. Shlobin, S. Ahmad, and et al. Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis Respiration 76 2008 288 294
12. H.F. Nadrous, P.A. Pellikka, M.J. Krowka, and et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis Chest 128 2005 2393 2399
13. R.P. Baughman, P.J. Engel, L. Taylor, and E.E. Lower Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation Chest 138 2010 1078 1085
14. A.B. Lumb The pulmonary circulation T. Horne, M. McMurray, Nun's Applied Respiratory Physiology Edition 7 2010 Elsevier Churchill Livingstone 99 117
15. S. Archer, and E. Michelakis The mechanism(s) of hypoxic pulmonary vasoconstriction: potassium channels, redox O(2) sensors, and controversies News Physiol Sci 17 2002 131 137
16. A.M. Gurney Multiple sites of oxygen sensing and their contributions to hypoxic pulmonary vasoconstriction Respir Physiol Neurobiol 132 2002 43 53
17. E.A. Coppock, J.R. Martens, and M.M. Tamkun Molecular basis of hypoxia-induced pulmonary vasoconstriction: role of voltage-gated K+ channels Am J Physiol Lung Cell Mol Physiol 281 2001 L1 12
18. P.I. Aaronson, T.P. Robertson, and J.P. Ward Endothelium-derived mediators and hypoxic pulmonary vasoconstriction Respir Physiol Neurobiol 132 2002 107 120
19. J.P. Ward, and T.P. Robertson The role of the endothelium in hypoxic pulmonary vasoconstriction Exp Physiol 80 1995 793 801
20. L.A. Shimoda, J.S. Sham, Q. Liu, and J.T. Sylvester Acute and chronic hypoxic pulmonary vasoconstriction: a central role for endothelin-1? Respir Physiol Neurobiol 132 2002 93 106
21. D. Heath, E.H. Wood, J.W. Dushane, and J.E. Edwards The structure of the pulmonary trunk at different ages and in cases of pulmonary hypertension and pulmonary stenosis J Pathol Bacteriol 77 1959 443 456
22. A.C. Burton Relation of structure to function of the tissues of the wall of blood vessels Physiol Rev 34 1954 619 642
23. V.I. Peinado, S. Pizarro, and J.A. Barberà Pulmonary vascular involvement in COPD Chest 134 2008 808 814
24. P. Harris, N. Segel, I. Green, and E. Housley The influence of the airways resistance and alveolar pressure on the pulmonary vascular resistance in chronic bronchitis Cardiovasc Res 2 1968 84 92
25. W. Biernacki, G.A. Gould, K.F. Whyte, and D.C. Flenley Pulmonary hemodynamics, gas exchange, and the severity of emphysema as assessed by quantitative CT scan in chronic bronchitis and emphysema Am Rev Respir Dis 139 1989 1509 1515
26. W. MacNee Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part one Am J Respir Crit Care Med 150 1994 833 852
27. K. Horsfield, N. Segel, and J.M. Bishop The pulmonary circulation in chronic bronchitis at rest and during exercise breathing air and 80 per cent oxygen Clin Sci 34 1968 473 483
28. R.H. Wilson, W. Hoseth, and M.E. Dempsey The effects of breathing 99.6% oxygen on pulmonary vascular resistance and cardiac output in patients with pulmonary emphysema and chronic hypoxia Ann Intern Med 42 1955 629 637
29. G.M. Aber, T.J. Bayley, and J.M. Bishop Inter-relationships between renal and cardiac function and respiratory gas exchange in obstructive airways disease Clin Sci 25 1963 159 170
30. F. Sime, D. Peñaloza, and L. Ruiz Bradycardia, increased cardiac output, and reversal of pulmonary hypertension in altitude natives living at sea level Br Heart J 33 1971 647 657
31. R.E. Girgis, and S.C. Mathai Pulmonary hypertension associated with chronic respiratory disease Clin Chest Med 28 2007 219 232 x
32. S. Santos, V.I. Peinado, J. Ramirez, and et al. Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease Am J Respir Crit Care Med 167 2003 1250 1256
33. V.I. Peinado, J.A. Barbera, J. Ramirez, and et al. Endothelial dysfunction in pulmonary arteries of patients with mild COPD Am J Physiol 274 6 Pt 1 1998 L908 L913
34. J.A. Barberà, V.I. Peinado, S. Santos, J. Ramirez, J. Roca, and R. Rodriguez-Roisin Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers Am J Respir Crit Care Med 164 2001 709 713
35. Y. Su, W. Han, C. Giraldo, Y. De Li, and E.R. Block Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells Am J Respir Cell Mol Biol 19 1998 819 825
36. V.I. Peinado, J.A. Barberá, P. Abate, and et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease Am J Respir Crit Care Med 159 5 Pt 1 1999 1605 1611
37. J.A. Barberà, V.I. Peinado, and S. Santos Pulmonary hypertension in chronic obstructive pulmonary disease Eur Respir J 21 2003 892 905
38. N.F. Voelkel, S. Mizuno, and H.J. Bogaard The role of hypoxia in pulmonary vascular diseases: a perspective Am J Physiol Lung Cell Mol Physiol 304 2013 L457 L465
39. M.K. Steiner, O.L. Syrkina, N. Kolliputi, E.J. Mark, C.A. Hales, and A.B. Waxman Interleukin-6 overexpression induces pulmonary hypertension Circ Res 104 2009 236 244 28 p following 244
40. H. Karmouty-Quintana, T. Weng, L.J. Garcia-Morales, and et al. Adenosine A2B receptor and hyaluronan modulate pulmonary hypertension associated with chronic obstructive pulmonary disease Am J Respir Cell Mol Biol 49 2013 1038 1047
41. S. Eddahibi, A. Chaouat, N. Morrell, and et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease Circulation 108 2003 1839 1844
42. S.S. Ulasli, F.O. Eyuboglu, H. Verdi, and F.B. Atac Associations between endothelial nitric oxide synthase A/B, angiotensin converting enzyme I/D and serotonin transporter L/S gene polymorphisms with pulmonary hypertension in COPD patients Mol Biol Rep 40 2013 5625 5633
43. V.I. Peinado, J. Ramírez, J. Roca, R. Rodriguez-Roisin, and J.A. Barberà Identification of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease Am J Respir Cell Mol Biol 34 2006 257 263
44. M. Díez, J.A. Barberà, E. Ferrer, and et al. Plasticity of CD133+ cells: role in pulmonary vascular remodeling Cardiovasc Res 76 2007 517 527
45. A.T. Dinh-Xuan, T.W. Higenbottam, C.A. Clelland, and et al. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease N Engl J Med 324 1991 1539 1547
46. A. Giaid, and D. Saleh Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension N Engl J Med 333 1995 214 221
47. S.P. Nana-Sinkam, J.D. Lee, S. Sotto-Santiago, and et al. Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke Am J Respir Crit Care Med 175 2007 676 685
48. B.W. Christman, C.D. McPherson, J.H. Newman, and et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension N Engl J Med 327 1992 70 75
49. N. Segel, and J.M. Bishop The circulation in patients with chronic bronchitis and emphysema at rest and during exercise, with special reference to the influence of changes in blood viscosity and blood volume on the pulmonary circulation J Clin Invest 45 1966 1555 1568
50. L. Farkas, J. Gauldie, N.F. Voelkel, and M. Kolb Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors Am J Respir Cell Mol Biol 45 2011 1 15
51. M. Colombat, H. Mal, O. Groussard, and et al. Pulmonary vascular lesions in end-stage idiopathic pulmonary fibrosis: Histopathologic study on lung explant specimens and correlations with pulmonary hemodynamics Hum Pathol 38 2007 60 65
52. A.G. Agustí, J. Roca, J. Gea, P.D. Wagner, A. Xaubet, and R. Rodriguez-Roisin Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis Am Rev Respir Dis 143 1991 219 225
53. D. Saleh, K. Furukawa, M.S. Tsao, and et al. Elevated expression of endothelin-1 and endothelin-converting enzyme-1 in idiopathic pulmonary fibrosis: possible involvement of proinflammatory cytokines Am J Respir Cell Mol Biol 16 1997 187 193
54. D.J. Abraham, R. Vancheeswaran, M.R. Dashwood, and et al. Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease Am J Pathol 151 1997 831 841
55. L. Farkas, D. Farkas, K. Ask, and et al. VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats J Clin Invest 119 2009 1298 1311
56. R.P. Charbeneau, and M. Peters-Golden Eicosanoids: mediators and therapeutic targets in fibrotic lung disease Clin Sci (Lond) 108 2005 479 491
57. L. Wright, R.M. Tuder, J. Wang, C.D. Cool, R.A. Lepley, and N.F. Voelkel 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension Am J Respir Crit Care Med 157 1998 219 229
58. S. Guiducci, O. Distler, J.H. Distler, and M. Matucci-Cerinic Mechanisms of vascular damage in SSc-implications for vascular treatment strategies Rheumatology (Oxford) 47 Suppl 5 2008 v18 v20
59. H. Nunes, M. Humbert, F. Capron, and et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis Thorax 61 2006 68 74
60. T. Takemura, Y. Matsui, S. Saiki, and R. Mikami Pulmonary vascular involvement in sarcoidosis: a report of 40 autopsy cases Hum Pathol 23 1992 1216 1223
61. R.M. Jones, A. Dawson, G.H. Jenkins, A.G. Nicholson, D.M. Hansell, and N.K. Harrison Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis Eur Respir J 34 2009 517 520
62. F. Portier, G. Lerebours-Pigeonniere, L. Thiberville, and et al. Sarcoidosis simulating a pulmonary veno-occlusive disease Rev Mal Respir 8 1991 101 102
63. V. Hoffstein, N. Ranganathan, and J.B. Mullen Sarcoidosis simulating pulmonary veno-occlusive disease Am Rev Respir Dis 134 1986 809 811
64. F. Reichenberger, J. Schauer, K. Kellner, U. Sack, P. Stiehl, and J. Winkler Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases Lung 179 2001 163 174
65. C. Letizia, A. Danese, M.G. Reale, and et al. Plasma levels of endothelin-1 increase in patients with sarcoidosis and fall after disease remission Panminerva Med 43 2001 257 261
66. O.A. Shlobin, and S.D. Nathan Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation Eur Respir J 39 2012 1520 1533